Clinical Trial Update: A Trial of FANG™ Vaccine for Participants With Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for the FANG Vaccine in ovarian cancer; the study is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• FANG™ Vaccine

Snippet

Sponsor: Gradalis, Inc. | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-03-24